nelfinavir has been researched along with Breast Cancer in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, A; Mao, Q; Unadkat, JD; Zhang, Y | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Andrews, DW; Ba-Alawi, W; Branchard, E; Cescon, DW; Cruickshank, J; Gendoo, DMA; Gross, PL; Haibe-Kains, B; Longo, J; Penn, LZ; Schormann, W; Silvester, J; van Leeuwen, JE | 1 |
| Garcia-Orad, A; Gutierrez-Camino, A; Lopez-Lopez, E; Martin-Guerrero, I | 1 |
| Kapoor, S | 1 |
| Abdel-Mageed, AB; Chakravarty, G; Datta, A; Gerlach, S; Mallade, P; Mathur, A; Mondal, D; Srivastav, S; Willis, J | 1 |
| Bianco, R; Campiglia, P; D'Alessio, M; D'Angelo, D; Forestieri, P; Formisano, P; Iaccarino, G; Illario, M; Limite, G; Maione, AS; Rusciano, MR; Soprano, M; Sorriento, D | 1 |
| Chen, TC; Cho, HY; Gaffney, KJ; Golden, EB; Hofman, FM; Louie, SG; Petasis, NA; Schönthal, AH; Thomas, S | 1 |
| Brüning, A; Burges, A; Friese, K; Mylonas, I | 1 |
| Agarwal, P; Chen, TC; Cho, H; Gaffney, KJ; Golden, EB; Hofman, FM; Louie, SG; Petasis, NA; Schönthal, AH; Sharma, N; Thomas, S | 1 |
| Beebe, K; Han, I; Liu, JO; Nahta, R; Neckers, L; Rao, R; Shim, JS | 1 |
1 review(s) available for nelfinavir and Breast Cancer
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
10 other study(ies) available for nelfinavir and Breast Cancer
| Article | Year |
|---|---|
HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2).
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Cells, Cultured; Drug Resistance, Neoplasm; Gene Expression; HIV Protease Inhibitors; Humans; Indinavir; Mitoxantrone; Nelfinavir; Neoplasm Proteins; Ritonavir; Saquinavir; Tritium | 2004 |
Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.
Topics: Breast Neoplasms; Cadherins; Cholesterol; Clotrimazole; Dipyridamole; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Nelfinavir; Pharmacogenetics; Vemurafenib | 2022 |
Re: novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Female; HIV Protease Inhibitors; HSP90 Heat-Shock Proteins; Humans; Nelfinavir; Receptor, ErbB-2 | 2013 |
Re: selective inhibition of Her2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Female; HIV Protease Inhibitors; HSP90 Heat-Shock Proteins; Humans; Nelfinavir; Receptor, ErbB-2 | 2013 |
Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells.
Topics: Animals; Breast Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nelfinavir; Xenograft Model Antitumor Assays | 2016 |
Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Female; HIV Protease Inhibitors; Humans; Nelfinavir; Oxidative Stress; Reactive Oxygen Species; Tumor Cells, Cultured | 2016 |
Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; Colony-Forming Units Assay; DNA, Neoplasm; Doxorubicin; Endoplasmic Reticulum; Enzyme-Linked Immunosorbent Assay; Female; HIV Protease Inhibitors; Humans; Nelfinavir; Pyrazoles; Sulfonamides | 2009 |
Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells.
Topics: Activating Transcription Factor 3; Antineoplastic Agents, Hormonal; Apoptosis; Autophagy; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Glutathione; HIV Protease Inhibitors; Humans; Nelfinavir; Poly(ADP-ribose) Polymerases; Tamoxifen; Time Factors | 2010 |
Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Chloroquine; Endoplasmic Reticulum Stress; Female; Humans; MCF-7 Cells; Mice; Mice, Nude; Nelfinavir; Pyrazoles; Sulfonamides; Xenograft Model Antitumor Assays | 2012 |
Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Female; Fluorescent Antibody Technique; HIV Protease Inhibitors; HSP90 Heat-Shock Proteins; Humans; Immunoblotting; Immunoprecipitation; Mice; Mice, Nude; Middle Aged; Nelfinavir; Protein Conformation; Receptor, ErbB-2; Regression Analysis; Signal Transduction; Transplantation, Heterologous | 2012 |